|
Volumn 17, Issue 5, 2015, Pages 466-467
|
Understanding cardiogenic shock
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CONTRAST MEDIUM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
OPIATE;
ACUTE HEART FAILURE;
ANGIOCARDIOGRAPHY;
ARTIFICIAL VENTILATION;
CARDIOGENIC SHOCK;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
CORONARY ARTERY DISEASE;
EDITORIAL;
HEART AFTERLOAD;
HEART ASSIST DEVICE;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART MUSCLE ISCHEMIA;
HEART PRELOAD;
HEART SURGERY;
HEART TRANSPLANTATION;
HOSPITAL ADMISSION;
HUMAN;
INFLAMMATION;
INTENSIVE CARE UNIT;
MEDICAL DECISION MAKING;
MITRAL VALVE REGURGITATION;
MITRAL VALVE REPLACEMENT;
MULTIPLE ORGAN FAILURE;
PATHOPHYSIOLOGY;
PATIENT SELECTION;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PRIORITY JOURNAL;
PULMONARY ARTERY CATHETER;
FEMALE;
MALE;
MORTALITY;
SHOCK, CARDIOGENIC;
FEMALE;
HUMANS;
MALE;
SHOCK, CARDIOGENIC;
|
EID: 84928624058
PISSN: 13889842
EISSN: 18790844
Source Type: Journal
DOI: 10.1002/ejhf.265 Document Type: Editorial |
Times cited : (11)
|
References (8)
|